BIOMAT Database Logo BIOMAT Database Logo

[Prosthetic treatment of periodontal disease in epileptics]. 1976

T Raffay

UI MeSH Term Description Entries
D010510 Periodontal Diseases Pathological processes involving the PERIODONTIUM including the gum (GINGIVA), the alveolar bone (ALVEOLAR PROCESS), the DENTAL CEMENTUM, and the PERIODONTAL LIGAMENT. Parodontosis,Pyorrhea Alveolaris,Disease, Periodontal,Diseases, Periodontal,Parodontoses,Periodontal Disease
D010515 Periodontal Prosthesis Any restorative and replacement device that is used as a therapeutic aid in the treatment of periodontal disease. It is an adjunct to other forms of periodontal therapy and does not cure periodontal disease by itself. (Boucher's Clinical Dental Terminology, 3d ed) Periodontal Prostheses,Prostheses, Periodontal,Prosthesis, Periodontal
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Raffay
Periodontal, implant, and prosthetic treatment for advanced periodontal disease.
May 1997, Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995),
T Raffay
[Case of prosthetic treatment for severe periodontal disease].
April 2008, Nihon Hotetsu Shika Gakkai zasshi,
T Raffay
[Purpose and basis for prosthetic treatment in periodontal disease].
January 1985, Protetyka stomatologiczna,
T Raffay
Prosthetic oral rehabilitation after treatment of serious periodontal disease.
October 1982, Quintessence international, dental digest,
T Raffay
[Prosthetic treatment of periodontal diseases].
May 1970, Zeitschrift fur Allgemeinmedizin,
T Raffay
[Prosthetic treatment of periodontal diseases].
January 1970, Stomatoloski glasnik Srbije,
T Raffay
[Periodontal aspects of prosthetic treatment].
March 1981, Die Quintessenz,
T Raffay
Endodontic complications following periodontal and prosthetic treatment of patients with advanced periodontal disease.
February 1984, Journal of periodontology,
T Raffay
[The problem of prosthetic treatment in a case of periodontal disease].
January 1975, Zahntechnik; Zeitschrift fur Theorie und Praxis der wissenschaftlichen Zahntechnik,
T Raffay
[Periodontal treatment of patients with periodontal-prosthetic problems].
January 1986, Stomatologia,
Copied contents to your clipboard!